Vaccine News and Research

Latest Vaccine News and Research

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

A new preprint research paper posted to the bioRxiv server demonstrates the potential of using the pre-existing protective responses to produce a broad-spectrum neutralizing response against not just SARS-CoV-2 but other future pathogens.

14 Feb 2021

New mouse model of SARS-CoV-2 infection reflects features of human infection

Now, a new preprint research paper posted to the bioRxiv server reports the development of a modified mouse model that allows productive SARS-CoV-2 infection of the mouse lungs, as well as the exploration of type I and III interferon responses in this condition.

14 Feb 2021

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

14 Feb 2021

In search of the shot

Too little covid vaccine and too great a demand: That's what KHN readers from around the country detail in their often exasperating quest to snag a shot, although they are often clearly eligible under their local guidelines and priority system.

13 Feb 2021

How effective has the COVID-19 vaccination program been in Israel?

Using publicly available coronavirus disease 2019 (COVID-19) data from Israel, a study suggests the BioNTech-Pfizer BNT162b2 vaccine is proving highly effective in the real world.

12 Feb 2021

S.D. governor gives state high marks in handling the pandemic. Are they deserved?

Covid-19 has pushed states to adopt unique approaches to protect their residents, but few have garnered as much scrutiny as South Dakota.

12 Feb 2021

Scientists demonstrate how glue points and sequence alignment information can flag residue SARS-CoV-2 variants

Researchers in the U.S. have demonstrated how dominant energetic landscape mappings or glue points, along with sequence alignment information can potentially identify key residue mutations and spike protein deletions tied with emerging variants.

12 Feb 2021

People previously infected with COVID-19 respond strongly to one dose of Pfizer vaccine

Although clinical trial data are encouraging, real-world evidence with regard to the COVID-19 vaccine remains scarce. In particular, response to the vaccine among those previously infected with SARS-CoV-2 is still not completely understood.

12 Feb 2021

Researchers identify a pathway used by filoviruses to enter cells

It was once thought that Ebola and related filoviruses were more or less contained to Central Africa.

11 Feb 2021

New SARS-CoV-2 variant found in newborn child with seizures in the United States

Researchers at a hospital in Washington D.C. found a new mutant strain of the virus in a neonatal patient with high viral loads. According to the authors, this strain could be spreading in the United States mid-Atlantic population and needs monitoring.

11 Feb 2021

UC San Diego and County of San Diego test early alert system to detect SARS-CoV-2 at schools

In an effort to help schools reduce the risk of COVID-19 outbreaks as they resume in-person instruction, University of California San Diego and the County of San Diego are testing the Safer at School Early Alert system, an evidence-informed program to detect SARS-CoV-2 at schools and child care centers.

11 Feb 2021

Vaccine equity is ‘North Star,’ feds say, and clinics are key to fair distribution

Mary Barnett is one of about a dozen seniors who got a covid vaccine on a recent morning at Neighborhood Health, a clinic tucked in a sprawling public housing development on the south side of downtown Nashville, Tennessee.

11 Feb 2021

Tech companies mobilize to schedule vaccine appointments, but often fall short

On Jan. 14 at 8:43 p.m., Patrick McKenzie tweeted a plea for tech engineers to help him set up a website to track covid-19 vaccine availability in California. McKenzie, who heads a Bay Area financial services tech company, issued the call to "anyone in California [who] wants to do a civtech project which matters."

11 Feb 2021

New study shares preliminary data on Pfizer vaccine’s effectiveness in Israel

Researchers have shown that by mid-January, the number of COVID-19 cases and hospitalizations in Israel began to decline with a larger and earlier decrease among older people.

11 Feb 2021

Pediatric dietary mobile game improved children’s short-term food choices

Rates of overweight and obesity in children are rising around the world, with serious long-term consequences for health and health care costs. In prior research, video and mobile games have helped children eat healthier and exercise more.

11 Feb 2021

Minimally-invasive deep aging clocks could improve response to COVID-19 vaccine

Deep Longevity, a fully-owned subsidiary of Regent Pacific (SEHK:0575.HK), specializing in the development and the application of next-generation artificial intelligence (AI) for aging and longevity research, today announced the publication of an article in Lancet Healthy Longevity titled "The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19".

11 Feb 2021

COVID-19 immunity study to enroll college students to test vaccine effectiveness

A University of Arizona Health Sciences study that is examining COVID-19 immunity and re-infection among frontline workers is expanding to include some Arizona college students while broadening its research focus to include COVID-19 vaccination effectiveness.

11 Feb 2021

1918 pandemic provides a cautionary tale of potential future pandemic

The 1918 influenza pandemic provides a cautionary tale for what the future may hold for COVID-19, says a Michigan State University researcher.

10 Feb 2021

Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals

Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may not offer any additional protection against coronavirus disease 2019 (COVID-19) over one dose among individuals previously infected with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

10 Feb 2021

Substrain of SARS-CoV-2 variant in UK may resist antibody neutralization

Researchers at the Polish Academy of Sciences in Warsaw have identified a substrain of the recently emerged B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may confer resistance to antibody neutralization.

10 Feb 2021

Vaccine News and Research

Latest Vaccine News and Research

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

New mouse model of SARS-CoV-2 infection reflects features of human infection

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

In search of the shot

How effective has the COVID-19 vaccination program been in Israel?

S.D. governor gives state high marks in handling the pandemic. Are they deserved?

Scientists demonstrate how glue points and sequence alignment information can flag residue SARS-CoV-2 variants

People previously infected with COVID-19 respond strongly to one dose of Pfizer vaccine

Researchers identify a pathway used by filoviruses to enter cells

New SARS-CoV-2 variant found in newborn child with seizures in the United States

UC San Diego and County of San Diego test early alert system to detect SARS-CoV-2 at schools

Vaccine equity is ‘North Star,’ feds say, and clinics are key to fair distribution

Tech companies mobilize to schedule vaccine appointments, but often fall short

New study shares preliminary data on Pfizer vaccine’s effectiveness in Israel

Pediatric dietary mobile game improved children’s short-term food choices

Minimally-invasive deep aging clocks could improve response to COVID-19 vaccine

COVID-19 immunity study to enroll college students to test vaccine effectiveness

1918 pandemic provides a cautionary tale of potential future pandemic

Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals

Substrain of SARS-CoV-2 variant in UK may resist antibody neutralization

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in